Lam Research Corporation (LRCX)

Basic

  • Market Cap

    $92.67B

  • EV

    $92.5B

  • Shares Out

    131.79M

  • Revenue

    $15.84B

  • Employees

    17,200

Margins

  • Gross

    45.34%

  • EBITDA

    31.49%

  • Operating

    29.24%

  • Pre-Tax

    28.29%

  • Net

    25.08%

  • FCF

    28.43%

Returns (5Yr Avg)

  • ROA

    16.46%

  • ROE

    58.37%

  • ROCE

    34.22%

  • ROIC

    41.55%

Valuation (TTM)

  • P/E

  • P/B

  • EV/Sales

  • EV/EBITDA

  • EV/FCF

  • EV/Gross Profit

Valuation (NTM)

  • Price Target

    $702.8

  • P/E

  • EV/Sales

  • EV/EBITDA

  • EV/FCF

Per Share

  • Rev

    $117.83

  • Earnings (Dil)

    $29.46

  • FCF

    $33.39

  • Book Value

    $60.93

Growth (CAGR)

  • Rev 3Yr

    12.72%

  • Rev 5Yr

    7.7%

  • Rev 10Yr

    15.63%

  • Dil EPS 3Yr

    18.74%

  • Dil EPS 5Yr

    17.42%

  • Dil EPS 10Yr

    38.3%

  • Rev Fwd 2Yr

    -0.42%

  • EBITDA Fwd 2Yr

    -0.46%

  • EPS Fwd 2Yr

    1.31%

  • EPS LT Growth Est

    9.01%

Dividends

  • Yield

  • Payout

    24.27%

  • DPS

    $7.18

  • DPS Growth 3Yr

    14.74%

  • DPS Growth 5Yr

    17.53%

  • DPS Growth 10Yr

  • DPS Growth Fwd 2Yr

    10.65%

Select a metric from the list below to chart it

Jun '14
Jun '16
Jun '18
Jun '20
Jun '22
LTM

Total Revenues

9,653.6

10,044.7

14,626.2

17,227.0

17,428.5

15,836.5

Total Revenues % Chg.

-12.9%

4.1%

45.6%

17.8%

1.2%

-12.0%

Cost of Goods Sold, Total

5,295.1

5,436.0

7,820.8

9,355.2

9,573.4

8,655.6

Gross Profit

4,358.5

4,608.7

6,805.3

7,871.8

7,855.1

7,180.9

Selling General & Admin Expenses, Total

702.4

682.5

829.9

885.7

832.8

834.2

R&D Expenses

1,191.3

1,252.4

1,493.4

1,604.2

1,727.2

1,716.4

Other Operating Expenses, Total

1,893.7

1,934.9

2,323.3

2,490.0

2,559.9

2,550.6

Operating Income

2,464.7

2,673.8

4,482.0

5,381.8

5,295.2

4,630.3

Interest Expense, Total

-117.3

-177.4

-208.6

-184.8

-186.5

-185.7

Interest And Investment Income

98.8

85.4

19.7

15.2

139.0

180.5

Net Interest Expenses

-18.5

-92.0

-188.9

-169.6

-47.5

-5.2

Currency Exchange Gains (Loss)

0.8

-3.3

-7.0

-0.7

-7.1

-12.6

Other Non Operating Income (Expenses)

-0.5

-3.5

84.7

-18.4

-11.1

-2.1

EBT, Excl. Unusual Items

2,446.6

2,575.0

4,370.8

5,193.1

5,229.5

4,610.4

Restructuring Charges

-120.3

-130.3

Merger & Related Restructuring Charges

Impairment of Goodwill

Gain (Loss) On Sale Of Investments

Gain (Loss) On Sale Of Assets

Asset Writedown

Other Unusual Items

EBT, Incl. Unusual Items

2,446.6

2,575.0

4,370.8

5,193.1

5,109.2

4,480.1

Income Tax Expense

255.1

323.2

462.3

587.8

598.3

507.6

Earnings From Continuing Operations

2,191.4

2,251.8

3,908.5

4,605.3

4,510.9

3,972.5

Net Income

2,191.4

2,251.8

3,908.5

4,605.3

4,510.9

3,972.5

Net Income to Common Incl Extra Items

2,191.4

2,251.8

3,908.5

4,605.3

4,510.9

3,972.5

Net Income to Common Excl. Extra Items

2,191.4

2,251.8

3,908.5

4,605.3

4,510.9

3,972.5

Total Shares Outstanding

144.4

145.3

142.5

137.0

133.3

132.1

Weighted Avg. Shares Outstanding

152.5

144.8

143.6

139.9

135.5

134.4

Weighted Avg. Shares Outstanding Dil

159.9

149.1

145.3

140.6

135.8

134.8

EPS

14.4

15.5

27.2

32.9

33.3

29.6

EPS Diluted

13.7

15.1

26.9

32.8

33.2

29.5

EBITDA

2,774.0

2,942.3

4,789.2

5,715.6

5,637.6

4,987.5